Literature DB >> 17090907

Acute liver failure.

Sanjay Bansal1, Anil Dhawan.   

Abstract

Acute liver failure in children is a rare but potentially fatal disease. Causes of ALF in neonatal period are different from those in early or late childhood. Despite the improvement in the paediatric intensive care, liver transplantation remains the only effective treatment. Use of newer treatment modalities (liver assist devices and hepatocyte transplantation) is still in experimental phase. Management requires early recognition, prompt diagnosis of treatable condition, supportive therapy and prevention of complications hence these children should ideally be treated in a specialist unit.

Entities:  

Mesh:

Year:  2006        PMID: 17090907      PMCID: PMC7101995          DOI: 10.1007/bf02859289

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  12 in total

Review 1.  Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review.

Authors:  Lise L Kjaergard; Jianping Liu; Bodil Als-Nielsen; Christian Gluud
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

2.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

3.  Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial.

Authors:  A J Ellis; J A Wendon; R Williams
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

Review 4.  Fulminant hepatic failure: pediatric aspects.

Authors:  B R Bhaduri; G Mieli-Vergani
Journal:  Semin Liver Dis       Date:  1996-11       Impact factor: 6.115

5.  Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure.

Authors:  R Girlanda; H Vilca-Melendez; P Srinivasan; P Muiesan; J G O'Grady; M Rela; N D Heaton
Journal:  Transplant Proc       Date:  2005-05       Impact factor: 1.066

6.  The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers.

Authors:  Jan Stange; Tarek I Hassanein; Ravindra Mehta; Steffen R Mitzner; Robert H Bartlett
Journal:  Artif Organs       Date:  2002-02       Impact factor: 3.094

7.  Renal failure in children with hepatic failure undergoing liver transplantation.

Authors:  D Ellis; E D Avner; T E Starzl
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

8.  The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure.

Authors:  Nicholas Murphy; Georg Auzinger; William Bernel; Julia Wendon
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

9.  Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure.

Authors:  A Forbes; G J Alexander; J G O'Grady; R Keays; R Gullan; S Dawling; R Williams
Journal:  Hepatology       Date:  1989-09       Impact factor: 17.425

10.  Early indicators of prognosis in fulminant hepatic failure.

Authors:  J G O'Grady; G J Alexander; K M Hayllar; R Williams
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

View more
  2 in total

1.  Enhanced expressions and activations of leukotriene C4 synthesis enzymes in D-galactosamine/lipopolysaccharide-induced rat fulminant hepatic failure model.

Authors:  Kui-Fen Ma; Hong-Yu Yang; Zhe Chen; Luo-Yang Qi; Dan-Yan Zhu; Yi-Jia Lou
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

2.  Validity of pediatric index of mortality 2 (PIM2) score in pediatric acute liver failure.

Authors:  Claire Elizabeth Matthews; Chulananda Goonasekera; Anil Dhawan; Akash Deep
Journal:  Crit Care       Date:  2014-12-02       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.